Analysis | Metabolite Name | Measured Value | Units | Organ | Cancer status | Smoker | Gender |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | heptadecanoic acid NIST | 98 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 145 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 155 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 176 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 190 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 200 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 212 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 212 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 217 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 217 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 220 | Peak area | Serum | Adenosquamous | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 221 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 230 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 231 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 233 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 233 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 235 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 236 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 238 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 246 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 248 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 249 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 250 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 254 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 254 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 254 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 254 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 256 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 260 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 262 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 262 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 263 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 272 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 277 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 279 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 289 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 289 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 291 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 291 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 291 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 293 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 295 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 295 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 295 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 297 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 300 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 304 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 304 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 306 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 308 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 309 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 314 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 315 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 316 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 319 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 320 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 322 | Peak area | Serum | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 324 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 325 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 328 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 328 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 333 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 335 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 336 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 339 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 347 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 350 | Peak area | Plasma | Adenosquamous | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 351 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 354 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 357 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 364 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 365 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 369 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 370 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 371 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 373 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 374 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 375 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 376 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 376 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 377 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 378 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 386 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 386 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 387 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 388 | Peak area | Plasma | Adenosquamous | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 389 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 389 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 390 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 391 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 398 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 400 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 403 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 406 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 407 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 408 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 419 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 420 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 422 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 425 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 426 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 427 | Peak area | Serum | Adenosquamous | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 428 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 429 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 440 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 441 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 441 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 445 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 447 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 449 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 453 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 453 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 453 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 454 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 456 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 459 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 468 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 470 | Peak area | Plasma | Adenosquamous | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 471 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 473 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 475 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 483 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 488 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 491 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 491 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 492 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 515 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 522 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 528 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 531 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 532 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 536 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 536 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 543 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 556 | Peak area | Serum | Adenosquamous | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 560 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 561 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 562 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 569 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 571 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 571 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 587 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 589 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 593 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 598 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 598 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 603 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 612 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 623 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 634 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 639 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 647 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 656 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 679 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 689 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 691 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 692 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 694 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 703 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 704 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 732 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 733 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 736 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 740 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 759 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 962 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 982 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 987 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1005 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1071 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1120 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1242 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1246 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1253 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1525 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1581 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1739 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 1937 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | heptadecanoic acid NIST | 2085 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 756 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | methylhexadecanoic acid | 796 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 809 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 828 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 828 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 828 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 842 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | methylhexadecanoic acid | 849 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 903 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 947 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 949 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 956 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | methylhexadecanoic acid | 964 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 968 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | methylhexadecanoic acid | 984 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 986 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 994 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 998 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1003 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1017 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | methylhexadecanoic acid | 1029 | Peak area | Serum | Adenocarcinoma | Former | F |
Return to search page